The State of Texas Attorney General Files Lawsuit Against Tylenol Makers Over Autism Claims

Legal Action
The Texas Attorney General, a Trump ally who is running for the United States Senate, alleged pharmaceutical manufacturers of concealing safety concerns of Tylenol

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of acetaminophen, asserting the companies withheld alleged dangers that the medication presented to pediatric neurological development.

The court filing follows four weeks after Former President Trump publicized an unsubstantiated connection between using acetaminophen - referred to as paracetamol - while pregnant and autism in offspring.

The attorney general is filing suit against J&J, which previously sold the drug, the exclusive pain medication suggested for pregnant women, and Kenvue, which now manufacturers it.

In a statement, he said they "betrayed America by making money from pain and marketing drugs regardless of the potential hazards."

Kenvue asserts there is insufficient reliable data connecting Tylenol to autism.

"These corporations misled for generations, deliberately risking countless individuals to increase profits," Paxton, a Republican, stated.

The manufacturer said in a statement that it was "deeply concerned by the spread of false claims on the safety of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its online platform, Kenvue also stated it had "regularly reviewed the applicable studies and there is insufficient valid information that demonstrates a proven link between taking acetaminophen and autism."

Groups speaking for medical professionals and healthcare providers share this view.

ACOG has said acetaminophen - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to treat pain and elevated temperature, which can pose serious health risks if not addressed.

"In more than two decades of research on the use of paracetamol in gestation, no reliable research has conclusively proven that the consumption of paracetamol in any period of gestation leads to neurological conditions in offspring," the organization stated.

The lawsuit references recent announcements from the former administration in claiming the medication is allegedly unsafe.

In recent weeks, the former president generated worry from medical authorities when he told pregnant women to "fight like hell" not to take Tylenol when ill.

The FDA then released a statement that medical professionals should think about restricting the use of acetaminophen, while also declaring that "a causal relationship" between the drug and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had vowed in spring to conduct "a massive testing and research effort" that would establish the cause of autism spectrum disorder in a limited time.

But experts cautioned that finding a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and disability that impacts how persons perceive and relate to the surroundings, and is identified using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is running for the Senate - alleges Kenvue and J&J "intentionally overlooked and attempted to silence the science" around acetaminophen and autism.

The case seeks to make the corporations "remove any commercial messaging" that asserts acetaminophen is secure for expectant mothers.

The Texas lawsuit parallels the complaints of a collection of parents of minors with autism and ADHD who filed suit against the manufacturers of Tylenol in two years ago.

Judicial authorities rejected the legal action, declaring studies from the parents' expert witnesses was lacking definitive proof.

Jeremy White
Jeremy White

Lena is a seasoned sports analyst with a passion for data-driven betting strategies and helping others make informed wagers.